Moderna Biopharma Canada

Communicating with government officials about pandemic and emergency planning, including the "Pandemic Preparedness Plan" being prepared by the Public Health Agency of Canada ("PHAC"). Communicating with government officials about vaccine production, more specifically opportunities to increase biomanufacturing capabilities in Canada, including at Moderna's facility in Laval, Québec. Communicating with government officials about procurement polices and procedures (including, but not limited to, those maintained by the Departments of Health and Public Services and Procurement), more specifically policies and procedures pertaining to the development, procurement and distribution of vaccines, including Moderna's messenger ribonucleic acid ("mRNA") vaccines. Communicating with government officials, in general, about pharmaceutical and biotechnology policies, including those related to innovation, research and development and messenger ribonucleic acid ("mRNA") biotechnology.

Communicating with government officials about vaccine production, more specifically opportunities to increase biomanufacturing capabilities in Canada. Communicating with government officials about procurement polices and procedures (including, but not limited to, those maintained by the Departments of Health and Public Services and Procurement), more specifically policies and procedures pertaining to the development, procurement and distribution of vaccines, including Moderna's messenger ribonucleic acid ("mRNA") vaccines. Communicating with government officials about pandemic and emergency planning, including the "Pandemic Preparedness Plan" being prepared by the Public Health Agency of Canada ("PHAC"). Communicating with government officials, in general, about pharmaceutical and biotechnology policies, including those related to innovation, research and development and messenger ribonucleic acid ("mRNA") biotechnology.

Communicating with government officials about vaccine production, more specifically opportunities to increase biomanufacturing capabilities in Canada. Communicating with government officials about procurement polices and procedures (including, but not limited to, those maintained by the Departments of Health and Public Services and Procurement), more specifically policies and procedures pertaining to the development, procurement and distribution of vaccines, including Moderna's messenger ribonucleic acid ("mRNA") vaccines. Communicating with government officials about pandemic and emergency planning, including the "Pandemic Preparedness Plan" being prepared by the Public Health Agency of Canada ("PHAC"). Communicating with government officials, in general, about pharmaceutical and biotechnology policies, including those related to innovation, research and development and messenger ribonucleic acid ("mRNA") biotechnology. Communicating with government officials, in general, about pharmaceutical and biotechnology policies, including those related to innovation, research and development and messenger ribonucleic acid ("mRNA") biotechnology.

The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models Government policies regarding innovation, research and development, and messenger ribonucleic acid (mRNA) biotechnology